Related Experiment Videos

Preparation of cell-free feline oncornavirus-associated cell membrane antigen

Insights

Cell-free feline oncornavirus-associated cell membrane antigen (FOCMA) was isolated from a tumor-derived cell line. This antigen was detected in membrane fractions and papain-solubilized products, confirming its presence and potential role in feline tumors.

Area of Science:

  • Veterinary Immunology
  • Oncology
  • Virology

Background:

  • Feline oncornavirus-associated cell membrane antigen (FOCMA) is a key marker in feline leukemia virus (FeLV)-associated tumors.
  • Understanding FOCMA's expression and characteristics is crucial for diagnosing and potentially treating feline cancers.

Purpose of the Study:

  • To prepare and characterize cell-free FOCMA from a feline lymphoblastoid cell line.
  • To confirm the presence of FOCMA in specific cellular fractions and solubilized products.

Main Methods:

  • Utilized a feline lymphoblastoid cell line (FL-74) of tumor origin for antigen preparation.
  • Separated membrane fractions using sucrose density gradients.
  • Assessed FOCMA presence by its inhibitory capacity against reference cytotoxic cat antisera.

Main Results:

  • Successfully prepared cell-free feline oncornavirus-associated cell membrane antigen (FOCMA).
  • FOCMA was identified in membrane fractions and papain-solubilized products derived from the FL-74 cell line.
  • The antigen's presence was validated through its ability to inhibit cytotoxic cat antisera.

Conclusions:

  • Cell-free FOCMA can be effectively prepared from tumor-derived feline cell lines.
  • FOCMA is associated with membrane fractions and can be obtained in solubilized forms.
  • These findings support FOCMA's role as a target antigen in feline neoplastic diseases.

Related Concept Videos